Universitätsklinikum Hamburg-Eppendorf (UKE)

Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials (2018) Van Mackelenbergh MT, Denkert C, Nekljudova V, Karn T, Schem C, Marme F, Stickeler E, et al. Journal article Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment (2018) Bauer ECA, Schochter F, Widschwendter P, Degregorio A, Andergassen U, Friedl TWP, Fasching P, et al. Journal article Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer (2018) Banys-Paluchowski M, Fehm T, Janni W, Aktas B, Fasching P, Kasimir-Bauer S, Milde-Langosch K, et al. Journal article A Cross-Sectional Multicenter Study of Multidimensional Body Image in Adolescents and Adults with Gender Dysphoria Before and After Transition-Related Medical Interventions (2018) Becker I, Auer M, Barkmann C, Fuss J, Moeller B, Nieder TO, Fahrenkrug S, et al. Journal article BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study (2018) Fasching P, Loibl S, Hu C, Hart SN, Shimelis H, Moore R, Schem C, et al. Journal article Desire to Have Children Among Transgender People in Germany: A Cross-Sectional Multi-Center Study (2018) Auer MK, Fuss J, Nieder TO, Briken P, Biedermann S, Stalla GK, Beckmann M, Hildebrandt T Journal article Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial (2018) Stevic I, Mueller V, Weber K, Fasching P, Karn T, Marme F, Schem C, et al. Journal article The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer (2018) Banys-Paluchowski M, Witzel I, Riethdorf S, Pantel K, Rack B, Janni W, Fasching P, et al. Journal article Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial (2018) Ignatiadis M, Litiere S, Rothe F, Riethdorf S, Proudhon C, Fehma T, Aalders K, et al. Journal article Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry (2018) Witzel I, Laakmann E, Weide R, Neunhoeffer T, Park-Simon TJ, Schmidt M, Fasching P, et al. Journal article